05/12/2025
Want to help with COPD research?
Join our 32-week phase II COPD study which aims to assess the safety and tolerability of a newly developed anti-inflammatory medication for the treatment of COPD.
To be eligible to take part, you must:
π Have a COPD diagnosis for at least 1 year
π Be 40 to 75 years old
π Use a daily preventative inhaler (non-blue inhaler) for at least 3 months
π Be a former smoker for at least 6 months
Youβll be reimbursed for your travel up tp Β£200 per visit and for your time up to Β£1,500.
If you are interested, please contact us by:
π calling us at 0207 034 3342
π₯ emailing us at recruitment@heartlungcentre.com
π± or registering your interest on our website (link in bio)